Other potential bias. Isabelle Boutron French Cochrane Centre Bias Method Group University Paris Descartes

Similar documents
CONSORT extension. CONSORT for Non-pharmacologic interventions. Isabelle Boutron

Avoiding common errors in research reporting:

School of Dentistry. What is a systematic review?

ARCHE Risk of Bias (ROB) Guidelines

Controlled Trials. Spyros Kitsiou, PhD

Methods in Research on Research. The Peer Review Process. Why Evidence Based Practices Are Needed?

RoB 2.0: A revised tool to assess risk of bias in randomized trials

University of Bristol - Explore Bristol Research

Meta-analyses: analyses:

Risk of selection bias in randomised trials

Learning from Systematic Review and Meta analysis

Instrument for the assessment of systematic reviews and meta-analysis

CONSORT: missing missing data guidelines, the effects on HTA monograph reporting Yvonne Sylvestre

Models for potentially biased evidence in meta-analysis using empirically based priors

How to Conduct a Meta-Analysis

Cochrane Pregnancy and Childbirth Group Methodological Guidelines

Systematic Reviews and Meta-analysis in Aquatic therapy

Systematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%)

Greg Pond Ph.D., P.Stat.

Types of Data. Systematic Reviews: Data Synthesis Professor Jodie Dodd 4/12/2014. Acknowledgements: Emily Bain Australasian Cochrane Centre

Statistical considerations in indirect comparisons and network meta-analysis

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Results. NeuRA Treatments for internalised stigma December 2017

Systematic review with multiple treatment comparison metaanalysis. on interventions for hepatic encephalopathy

Systematic Reviews. Simon Gates 8 March 2007

Protocol Development: The Guiding Light of Any Clinical Study

4/10/2018. Choosing a study design to answer a specific research question. Importance of study design. Types of study design. Types of study design

Web appendix (published as supplied by the authors)

pc oral surgery international

User s guide to the checklist of items assessing the quality of randomized controlled trials of nonpharmacological treatment

Evidence Based Medicine

Systematic Reviews and Meta- Analysis in Kidney Transplantation

Systematic reviews & Meta-analysis

Study protocol v. 1.0 Systematic review of the Sequential Organ Failure Assessment score as a surrogate endpoint in randomized controlled trials

Meta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014

RARE-Bestpractices Conference

Are the likely benefits worth the potential harms and costs? From McMaster EBCP Workshop/Duke University Medical Center

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma

What is the Cochrane Collaboration? What is a systematic review?

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials(review)

Downloaded from:

Appendix. TABLE E-1 Search Terms

EBP STEP 2. APPRAISING THE EVIDENCE : So how do I know that this article is any good? (Quantitative Articles) Alison Hoens

Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist.

Determinants of quality: Factors that lower or increase the quality of evidence

Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor

Issues to Consider in the Design of Randomized Controlled Trials

Pneumococcal polysaccharide vaccines: Systematic review and meta-analysis of randomised controlled efficacy trials

Results. NeuRA Worldwide incidence April 2016

Traumatic brain injury

Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions

Empirical evidence on sources of bias in randomised controlled trials: methods of and results from the BRANDO study

Drug Class Literature Scan: Pancreatic Enzymes

A research report of the therapeutic effects of yoga for health and wellbeing Prepared at ScHARR for the British Wheel of Yoga

Welcome to the Louis Calder Memorial Library NW 10 Ave., Miami, FL 33136

Supplementary Online Content

Appendices. Appendix A Search terms

Why is ILCOR moving to GRADE?

Problem solving therapy

PROSPERO International prospective register of systematic reviews

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Clinical research in AKI Timing of initiation of dialysis in AKI

Results. NeuRA Hypnosis June 2016

American Journal of Internal Medicine

5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA

CONSORT 2010 checklist of information to include when reporting a randomised trial*

Evidence- and Value-based Solutions for Health Care Clinical Improvement Consults, Content Development, Training & Seminars, Tools

Journal Club The ELITE Trial. Sandra Katalinic, Pharmacy Resident University Hospital of Northern British Columbia April 28, 2010

The role of meta-analysis in the evaluation of the effects of early nutrition on neurodevelopment

Critical Appraisal. Dave Abbott Senior Medicines Information Pharmacist

Evidence-Based Medicine and Publication Bias Desmond Thompson Merck & Co.

Cluster Randomised Trials: Sources of Bias. Ada Keding Professor David Torgerson

Authors Introduction to Pragmatic Trials. and Stepped Wedge Designs. Sandra Eldridge

Animal-assisted therapy

Positive Results on Fecal Blood Tests

Continuous vs Intermittent Dosing of Antibiotics in Critically-Ill Patients

Inhaled nitric oxide: clinical evidence for use in adults

Announcement of revised tools to assess risk of bias in randomized trials and in non-randomized studies

Evidence Based Medicine

Appendix Document A1: Search strategy for Medline (1960 November 2015)

Evaluating and Interpreting Clinical Trials

ACR OA Guideline Development Process Knee and Hip

Systematic review: The effectiveness and safety of diclofenac for the. pain management after cesarean

Design and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP I 5/2/2016

Avoidable waste of research related to inadequate methods in clinical trials

The Royal College of Pathologists Journal article evaluation questions

PROSPERO International prospective register of systematic reviews

NeuRA Sleep disturbance April 2016

The SPIRIT Initiative: Defining standard protocol items

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD

Results. NeuRA Mindfulness and acceptance therapies August 2018

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.

Structural Approach to Bias in Meta-analyses

Summary of main challenges and future directions

Role of evidence from observational studies in the process of health care decision making

Garbage in - garbage out? Impact of poor reporting on the development of systematic reviews

Alcohol interventions in secondary and further education

Cochrane Bone, Joint & Muscle Trauma Group How To Write A Protocol

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests

Transcription:

Other potential bias Isabelle Boutron French Cochrane Centre Bias Method Group University Paris Descartes 1

Outlines RoB tool for specific design Cross over trial Cluster randomized controlled trials Mono vs multicentric trials 2

The Risk of Bias Tool 3 http://www.cochrane-handbook.org/

Other risk of bias Baseline imbalance Imbalance in factors that are strongly related to outcome measures Blocked randomization in unblinded trials Differential diagnostic activity Adverse event of the drug could lead to specific exams and differential diagnostic activities Design-specific risks of bias 4

Design-specific risks of bias 5

Cross over trials Was use of a cross-over design appropriate? Stable condition Is it clear that the order of receiving treatments was randomized? Can it be assumed that the trial was not biased from carry-over effects? Are unbiased data available? Only first period data are available: High risk of bias 6

Cluster RCTs Recruitment bias Baseline imbalance Loss of clusters Incorrect analysis 7

Cluster RCTs Recruitment bias Individuals are recruited to the trial after the clusters have been randomized Knowledge of whether each cluster is an intervention or control cluster could affect the types of participants recruited Baseline imbalance related to the small number of clusters Loss of clusters Incorrect analysis 8 account for clustering in their analyses

Experimental treatment: Standardised consultation Education on osteoarthritis and treatment management; Information on physical exercises Information on weight loss Comparator: usual care Outcome: Weight and physical activities Recruitment: Rheumatologists recruited patients after knowing the treatment assignment. 9

Baseline data RECRUITMENT BIAS Standardised consultation: Weight (kg) = 84.1 (12.9) Usual care: Weight (kg) = 81.4 (13.6) 10

11

Recent research results 12 Ann Intern Med. 2011;155:39-51.

Discussion Two previous studies suggested that the results of single-center and multicenter RCTs could be different: In 1989, Berlin 1 suggested that single-center studies tended to show larger treatment effect on survival than did multicenter trials after adjustement for sample size In 2009, Bellomo 2 highlighted the limits of single-center RCTs in the field of critical care medicine: The results of many single-center RCTs have been contradicted when performed in multicenter setting 1 Berlin and colleagues. Journal of the American Statistical Association. 1989. 2 Bellomo and colleagues. Crit Care Med. 2009. 13

Methods Design Meta-epidemiological study on a collection of meta-analyses of binary outcomes Data sources and searches Meta-analyses of RCTs published in the Issue 4, 2008 of the Cochrane Collaboration and in Pubmed (high-impact factor journals) 48 Meta-analysis selected 421 RCTs contributing to the analysis 14

Results Interventions Single-center RCTs N=223 Multicenter RCTs N=198 Nonpharmacologic treatments 95 (43%) 86 (43%) Funding source Public 64 (29%) 56 (28%) Private 36 (16%) 102 (52%) Not reported 123 (55%) 40 (20%) Sample size (Median [Q1-Q3] 90 [50-153] 243 [126-521] Year of publication before 2000 98 (44%) 54 (27%) 15

Results RoB tool Sequence generation Single-center RCTs N=223 Multicenter RCTs N=198 Low risk of bias 75 (34%) 90 (45%) Allocation concealment Low risk of bias 32 (14%) 68 (34%) Blinding Low risk of bias 151 (68%) 157 (79%) Incomplete outcome data Low risk of bias 68 (31%) 55 (28%) Selective outcome reporting Low risk of bias 72 (32%) 134 (68%) Overall risk of bias Low risk of bias 11 (5%) 17 (9%) high risk of bias 39 (17%) 57 (29%) Unclear 173 (78%) 124 (62%) 16

17

Results Overall results ROR = 0.73 [0.64-0.83]; I 2 = 12% Subgroup analysis Non-pharmacologic treatments (NPT): ROR = 0.66 [0.53-0.82]; I 2 = 17% Pharmacologic treatments (PT): ROR = 0.80 [0.69-0.93]; I 2 = 3.3% Interaction between PT and NPT (p = 0.104) 18

Sensitivity analyses 19

26 meta-analysis (Cochrane) 292 RCTs 20

21

22

Discussion Possible explanations : «Small study effect» but the results were consistent after adjustment for sample size Publication bias: Some studies suggested that single-center RCTs may be more prone to publication bias than multicenter trials Sterne JA, et al JCE 2000 Sterne et al BMJ 1997 23

Discussion Possible explanations : Lower methodological quality of single-center RCTs but the results were consistent after adjustment for risk of bias Treatment effect really more important in single-center RCTs Selection of a more homogeneous population More standardized interventions in high skill units 24

Discussion Studies are needed to explore the different possible mechanisms The single-center or multicenter status is usually well reported in RCTs and simple to assess, so it could be used as a proxy measure when interpreting the results of meta-analysis 25